HealthLynked (HLYK) EBIT (2016 - 2026)

HealthLynked has disclosed EBIT across 11 years of filings, most recently posting -$800632.0 for Q1 2026.

• In Q1 2026, EBIT rose 14.04% year-over-year to -$800632.0; the TTM figure through Mar 2026 stood at -$3.0 million (down 183.94% YoY), while the FY2025 annual figure was -$688900.0, up 46.5% from the prior year.
• EBIT eased to -$800632.0 in Q1 2026, from -$735503.0 in the prior quarter.
• Over the last five years, EBIT for HLYK reached as high as $2.8 million in Q4 2023 and fell as low as -$4.1 million in Q4 2022.
• The 5-year median for EBIT is -$1.1 million (2023), against an average of -$826265.2.
• Annual changes were most pronounced in 2022 — EBIT slumped 422.58% — and 2023, when it jumped 168.13%.
• A 5-year view of EBIT shows it stood at -$4.1 million in 2022, then jumped by 168.13% to $2.8 million in 2023, then fell by 6.57% to $2.6 million in 2024, then slumped by 127.85% to -$735503.0 in 2025, then fell by 8.86% to -$800632.0 in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$800632.0, -$735503.0, and -$736654.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.